Eli Lilly and Novo Nordisk to maintain 'two-horse race' in GLP-1 weight loss market
U.Ozel.Images/E+ via Getty Images Although other companies are on the cusp of gaining approval for GLP-1 receptor agonist weight-loss drugs, ...
Tag: Eli
Deutsche Bank rates Eli Lilly as a “high-growth unicorn” and upgrades its rating to Buy (NYSE:LLY)
Eli Lilly (New York Stock Exchange:LLY) was in the spotlight on Monday after Deutsche Bank raised its rating on the ...
Eli Lilly and Novo extend their declines for several days in an unusual wave of sales (NYSE:LLY)
alexsl/E+ via Getty Images Shares of weight loss drug company Eli Lilly (New York Stock Exchange:LLY) and Novo Nordisk (NVO) ...
Analysts Reveal Eli Lilly Stock Price Targets After Earnings
The people of Eli Lilly (LYLY) They say they are working as fast as they can.The drugmaker, which reported its ...
Weight-loss drug prompts Eli Lilly to raise 2024 sales forecast by $2 billion By Reuters
By Bhanvi Satija and Patrick Wingrove(Reuters) -Explosive demand and increased manufacturing capacity for Eli Lilly's (NYSE:) weight-loss drug Zepbound led ...
Wall Street grapples with Eli Lilly's outlook By Investing.com
© Reuters. Explore the insights of Wall Street experts with this ProResearch article, available exclusively to InvestPro subscribers soon. Improve ...
Eli Lilly to add $4.1 billion in sales thanks to anti-obesity drug Zepbound
hapabapa/iStock Editorial via Getty Images Eli Lilly's Sales (New York Stock Exchange:LLY) recently approved weight-loss drug Zepbound could reach $4.1 ...
Eli Lilly slumps after cutting profit outlook despite rising weight-loss drug profits
Eli LillyLYLYIt posted better-than-expected third-quarter earnings on Thursday thanks to continued growth in sales of its anti-obesity drug Mounjaro, which ...
Eli Lilly Named Gilead Favorite at BofA Ahead of Q3 Earnings
in focus Heading into the biopharmaceutical sector's third-quarter earnings season, Bank of America has taken a bullish stance on Eli ...
Eli Lilly, Novo to lead weight loss drug market: JPMorgan
Fotolia/iStock via Getty Images JPMorgan recently raised its projections for weight loss drugs, expecting the drug category known as GLP-1 ...
Recommended.
